EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial
Recruiting
N/A
Interventional Study
Familial Melanoma
Fear of Cancer Recurrence
Eye Movement Desensitization and Reprocessing
Psychological Intervention
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Leiden University Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
High fear of cancer recurrence (FCR) impacts patient's quality of life (QoL) and is prevalent among patients with familial melanoma. The main objective is to investigate whether EMDR is effective in treating high FCR in patients with familial melanoma. The study design is a non-blinded, randomized waiting-list controlled trial. Patients aged 18 years or older with familial melanoma can be included…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* a score of 16 or higher on the FCRI-NL-SF
* 18 years or older
* diagnosed with familial melanoma
Exclusion Criteria:
* insufficient knowledge of the Dutch language.
* acute psychiatric disease (psychosis, suicidal ideation)
* variable dosis of anxiolytics
Contacts